These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 2139556
1. Serotonin-specific drugs for anxiety and depressive disorders. Charney DS, Krystal JH, Delgado PL, Heninger GR. Annu Rev Med; 1990; 41():437-46. PubMed ID: 2139556 [Abstract] [Full Text] [Related]
2. The clinical utility of pharmacological agents that act at serotonin receptors. Peroutka SJ, Sleight AJ, McCarthy BG, Pierce PA, Schmidt AW, Hekmatpanah CR. J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495 [Abstract] [Full Text] [Related]
7. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety. Murphy DL, Pigott TA. J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026 [Abstract] [Full Text] [Related]
8. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications]. Moulignier A. Rev Neurol (Paris); 1994 Apr; 150(1):3-15. PubMed ID: 7801037 [Abstract] [Full Text] [Related]
9. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link. Stahl SM. J Clin Psychiatry; 1997 Apr; 58 Suppl 8():20-6. PubMed ID: 9236732 [Abstract] [Full Text] [Related]
10. Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders. Fuller RW. J Clin Psychiatry; 1986 Apr; 47 Suppl():4-8. PubMed ID: 3514585 [Abstract] [Full Text] [Related]
11. Serotonin related functions in panic-anxiety: a critical overview. Coplan JD, Gorman JM, Klein DF. Neuropsychopharmacology; 1992 May; 6(3):189-200. PubMed ID: 1534662 [Abstract] [Full Text] [Related]
12. Serotonergic mechanisms and current and future psychiatric practice. Dubovsky SL, Thomas M. J Clin Psychiatry; 1995 May; 56 Suppl 2():38-48. PubMed ID: 7844106 [Abstract] [Full Text] [Related]
13. The marketing of 5-hydroxytryptamine: depression or anxiety? Healy D. Br J Psychiatry; 1991 Jun; 158():737-42. PubMed ID: 1873625 [No Abstract] [Full Text] [Related]
14. Drug treatment of anxiety and depression. Fox T. Practitioner; 1991 Sep; 235(1506):681-3. PubMed ID: 1796034 [No Abstract] [Full Text] [Related]
15. Approaches to developing new anxiolytics and antidepressants. Dubovsky SL. J Clin Psychiatry; 1993 May; 54 Suppl():75-83. PubMed ID: 8099580 [Abstract] [Full Text] [Related]